Table 3.
Acute Stroke Care Metrics in PR Hispanics Versus FL Hispanics
| AOR (95% CI) | PR Hispanic vs FL Hispanic (Reference) |
|---|---|
| IV tPA, arrive by 2 hours and treat by 3 hours | |
| AOR (95% CI) Model 1a | 0.19 (0.06–0.62) |
| AOR (95% CI) Model 2b | 0.55 (0.18–1.67) |
| AOR (95% CI) Model 3c | 0.46 (0.16–1.38) |
| Early antithrombotic use | |
| AOR (95% CI) Model 1 | 0.14 (0.06–0.33) |
| AOR (95% CI) Model 2 | 0.37 (0.12–1.14) |
| AOR (95% CI) Model 3 | 0.24 (0.10–0.59) |
| Antithrombotics at discharge | |
| AOR (95% CI) Model 1 | 0.10 (0.04–0.22) |
| AOR (95% CI) Model 2 | 0.19 (0.07–0.49) |
| AOR (95% CI) Model 3 | 0.27 (0.11–0.70) |
| Anticoagulation for atrial fibrillation | |
| AOR (95% CI) Model 1 | 0.39 (0.12–1.27) |
| AOR (95% CI) Model 2 | 0.81 (0.27–2.41) |
| AOR (95% CI) Model 3 | 0.76 (0.26–2.26) |
| Smoking cessation counseling | |
| AOR (95% CI) Model 1 | 0.26 (0.06–1.21) |
| AOR (95% CI) Model 2 | 0.49 (0.12–2.05) |
| AOR (95% CI) Model 3 | 0.49 (0.12–2.07) |
| LDL ≥100 mg/dL or ND—statin | |
| AOR (95% CI) Model 1 | 0.13 (0.06–0.28) |
| AOR (95% CI) Model 2 | 0.16 (0.08–0.35) |
| AOR (95% CI) Model 3 | 0.20 (0.09–0.41) |
| VTE prophylaxis | |
| AOR (95% CI) Model 1 | 0.23 (0.12–0.44) |
| AOR (95% CI) Model 2d | 0.24 (0.09–0.62) |
| AOR (95% CI) Model 3 | 0.27 (0.11–0.70) |
| Defect‐free care | |
| AOR (95% CI) Model 1 | 0.22 (0.12–0.45) |
| AOR (95% CI) Model 2 | 0.25 (0.11–0.54) |
| AOR (95% CI) Model 3 | 0.25 (0.12–0.55) |
AOR indicates adjusted odds ratio; FL, Florida; IV tPA, intravenous tissue plasminogen activator; LDL, low‐density lipoprotein; ND, not documented; PR, Puerto Rico; VTE, venous thromboembolism.
Model 1 adjusted for age and correlation within and between hospitals.
Model 2 additionally adjusted for age, health insurance status, mode of arrival and hospital‐level factors including number of beds, years in Get With the Guidelines‐Stroke, and academic vs not.
Model 3 includes variables in model 2 and patient National Institutes of Health Stroke Scale score, current smoker, hypertension, diabetes, dyslipidemia, and medical history of atrial fibrillation, coronary artery disease/prior myocardial infarction, and previous stroke/transient ischemic attack.
In order for this model to converge, health insurance status was not included as a covariate.